A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
Summary
This was a phase 3, randomised, assessor-blinded, multi-centre trial comparing the efficacy, safety and tolerability of a PICOPREP tailored dosing schedule to the PICOPREP day-before dosing schedule for colon cleansing in preparation for colonoscopy.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-06
- Completion
- 2015-06
Outcome
Met primary endpoint
paper Results Use of the PICOPREP TD regimen resulted in a statistically significant reduction in the mean total Ottawa Scale score compared to the PICOPREP DBD regimen (-3.93, 95 % confidence intervals [CI]: -4.99, -2.97; P < 0.0001) in the intent-to-treat analysis set. PMID 28393103 ↗
registry PICOPREP Day-before Dosing Schedule vs PICOPREP Tailored Dosing Schedule; p <0.0001; Adjusted estimated mean difference -3.93 (95% CI -4.99 to -2.87); ANCOVA; note: p-value corresponds to a two-sided test of superiority. NCT02239692 ↗
registry PICOPREP Day-before Dosing Schedule vs PICOPREP Tailored Dosing Schedule; p <0.0001; Adjusted estimated mean difference -4.38 (95% CI -5.34 to -3.41); ANCOVA; note: p-value corresponds to a two-sided test of superiority. NCT02239692 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PICOPREP | Small molecule | — | Oral |
Indications
No indication recorded.